Literature DB >> 11951886

Money for research participation: does in jeopardize informed consent?

C Grady1.   

Abstract

Some are concerned about the possibility that offering money for research participation can constitute coercion or undue influence capable of distorting the judgment of potential research subjects and compromising the voluntariness of their informed consent. The author recognizes that more often than not there are multiple influences leading to decisions, including decisions about research participation. The concept of undue influence is explored, as well as the question of whether or not there is something uniquely distorting about money as opposed to a chance for treatment or medical care. An amount of money that is not excessive and is calculated on the basis of time or contribution may, rather than constitute an undue inducement, be an indication of respect for the time and contribution that research subjects make.

Entities:  

Keywords:  Analytical Approach; Biomedical and Behavioral Research

Mesh:

Year:  2001        PMID: 11951886     DOI: 10.1162/152651601300169031

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  49 in total

1.  Methodological, practical, and ethical challenges to inner-city health research.

Authors:  Ahmed M Bayoumi; Stephen W Hwang
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

2.  The role of perceived benefits and costs in patients' medical decisions.

Authors:  Eleanor Singer; Mick P Couper; Angela Fagerlin; Floyd J Fowler; Carrie A Levin; Peter A Ubel; John Van Hoewyk; Brian J Zikmund-Fisher
Journal:  Health Expect       Date:  2011-11-10       Impact factor: 3.377

3.  Payment of research subjects involved in clinical trials is unethical.

Authors:  Mark Bernstein
Journal:  J Neurooncol       Date:  2003-07       Impact factor: 4.130

4.  The influence of risk and monetary payment on the research participation decision making process.

Authors:  J P Bentley; P G Thacker
Journal:  J Med Ethics       Date:  2004-06       Impact factor: 2.903

5.  Challenging assumptions about minority participation in US clinical research.

Authors:  Jill A Fisher; Corey A Kalbaugh
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

6.  Navigating the challenges of global reproductive health research.

Authors:  Amy L Stenson; Chisina T Kapungu; Stacie E Geller; Suellen Miller
Journal:  J Womens Health (Larchmt)       Date:  2010-09-19       Impact factor: 2.681

7.  Strategies to minimize risks and exploitation in phase one trials on healthy subjects.

Authors:  Adil E Shamoo; David B Resnik
Journal:  Am J Bioeth       Date:  2006 May-Jun       Impact factor: 11.229

Review 8.  Towards evidence based bioethics.

Authors:  Scott D Halpern
Journal:  BMJ       Date:  2005-10-15

9.  Phase I oncology trials: why the therapeutic misconception will not go away.

Authors:  W Glannon
Journal:  J Med Ethics       Date:  2006-05       Impact factor: 2.903

10.  Addressing standards of care in resource-limited settings.

Authors:  Liza Dawson; Karin L Klingman; Jeanne Marrazzo
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.